DK2038430T3 - Toll-Like-Receptor-4-dysfunktion og de biologiske anvendelser deraf - Google Patents

Toll-Like-Receptor-4-dysfunktion og de biologiske anvendelser deraf

Info

Publication number
DK2038430T3
DK2038430T3 DK07819905.6T DK07819905T DK2038430T3 DK 2038430 T3 DK2038430 T3 DK 2038430T3 DK 07819905 T DK07819905 T DK 07819905T DK 2038430 T3 DK2038430 T3 DK 2038430T3
Authority
DK
Denmark
Prior art keywords
tlr4
toll
receptor
subject
mutated
Prior art date
Application number
DK07819905.6T
Other languages
English (en)
Inventor
Lionel Apetoh
Guido Kroemer
Laurence Zitvogel
Original Assignee
Inst Gustave Roussy Igr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Gustave Roussy Igr filed Critical Inst Gustave Roussy Igr
Application granted granted Critical
Publication of DK2038430T3 publication Critical patent/DK2038430T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK07819905.6T 2006-07-18 2007-07-17 Toll-Like-Receptor-4-dysfunktion og de biologiske anvendelser deraf DK2038430T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06291164A EP1881080A1 (en) 2006-07-18 2006-07-18 Toll like receptor 4 dysfunction and the biological applications thereof
PCT/EP2007/057402 WO2008009693A1 (en) 2006-07-18 2007-07-17 Toll like receptor 4 dysfunction and the biological applications thereof

Publications (1)

Publication Number Publication Date
DK2038430T3 true DK2038430T3 (da) 2012-01-30

Family

ID=37402663

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07819905.6T DK2038430T3 (da) 2006-07-18 2007-07-17 Toll-Like-Receptor-4-dysfunktion og de biologiske anvendelser deraf

Country Status (7)

Country Link
US (1) US8557517B2 (da)
EP (2) EP1881080A1 (da)
JP (1) JP2009543570A (da)
AT (1) ATE537271T1 (da)
DK (1) DK2038430T3 (da)
ES (1) ES2378847T3 (da)
WO (1) WO2008009693A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009055076A2 (en) 2007-10-26 2009-04-30 Dynavax Technologies Corporation Methods and compositions for inhibition of immune responses and autoimmunity
WO2010020590A1 (en) * 2008-08-20 2010-02-25 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for predicting the response to anti-cancer treatment with an agonist of tlr7 or an agonist of tlr8
MX338980B (es) 2010-06-16 2016-05-06 Dynavax Tech Corp Metodos de tratamiento utilizando inhibidores de tlr7 y/o tlr9.
EP2681314B1 (en) * 2011-03-03 2017-11-01 Quark Pharmaceuticals, Inc. Compositions and methods for treating lung disease and injury
WO2012135824A2 (en) * 2011-03-31 2012-10-04 H. Lee Moffitt Cancer Center And Research Institute, Inc. Method of screening for colon cancer using biomarkers
WO2012139945A1 (en) * 2011-04-14 2012-10-18 Universidad De Navarra Method for predicting survival in cancer patients
WO2013122545A1 (en) * 2012-02-14 2013-08-22 National University Of Singapore Synergistic combinations for use in treating cancer
CN105517542B9 (zh) * 2013-08-27 2022-01-11 德国癌症研究中心 细胞毒性t细胞应答调节物
US10208332B2 (en) 2014-05-21 2019-02-19 Integenx Inc. Fluidic cartridge with valve mechanism
WO2016065073A1 (en) 2014-10-22 2016-04-28 Integenx Inc. Systems and methods for sample preparation, processing and analysis
AU2017264947B2 (en) 2016-05-13 2023-08-31 Medical & Biological Laboratories Co., Ltd. Peptide exchange system and method

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987006830A1 (en) 1986-05-09 1987-11-19 Sloan-Kettering Institute For Cancer Research Lipopolysaccharide and natural factor compositions for anti-tumor therapy and method of treatment
US6982252B2 (en) 2000-12-04 2006-01-03 Memorial Sloan-Kettering Cancer Center Inhibition of vacuolar proton ATPase activity and/or the modulation of acidic organelle function sensitizes cells to radiation, chemotherapy and biological agents
WO2002074921A2 (en) * 2001-03-19 2002-09-26 Cellular Genomics Inc. Methods for isolating proteins expressed by dendritic cells
US7195868B2 (en) * 2001-04-18 2007-03-27 Millennium Pharmaceuticals, Inc. Compositions and methods for the identification, assessment, prevention, and therapy of human cancers
GB0226251D0 (en) 2002-11-11 2002-12-18 San Raffaele Centro Fond Acetylated protein
US6916627B2 (en) 2002-11-27 2005-07-12 St. Jude Children's Research Hospital ATM kinase compositions and methods
WO2005040208A2 (en) * 2003-10-21 2005-05-06 Androclus Therapeutics, Soa Peptides derived from heat shock proteins binding toll-like receptors 2 and 4 and their use
WO2006014653A1 (en) * 2004-07-20 2006-02-09 Schering Corporation Induction of apoptosis in toll-like receptor expressing tumor cells
CA2587676A1 (en) * 2004-11-19 2006-05-26 Institut Gustave Roussy Improved treatment of cancer by double-stranded rna

Also Published As

Publication number Publication date
EP2038430A1 (en) 2009-03-25
US20100004161A1 (en) 2010-01-07
ES2378847T3 (es) 2012-04-18
EP1881080A1 (en) 2008-01-23
ATE537271T1 (de) 2011-12-15
US8557517B2 (en) 2013-10-15
JP2009543570A (ja) 2009-12-10
EP2038430B1 (en) 2011-12-14
WO2008009693A1 (en) 2008-01-24

Similar Documents

Publication Publication Date Title
ATE537271T1 (de) Toll-like-rezeptor-4-dysfunktion und biologische anwendungen davon
ATE527543T1 (de) Testvorrichtung zur schnelldiagnose
ATE556030T1 (de) Ultrasensitiver nachweis von analyten
PT2073008E (pt) Métodos de imunoensaio melhorados
WO2007112012A3 (en) Protein isoform discrimination and quantitative measurements thereof
TW200720441A (en) New labelling strategies for the sensitive detection of analytes
WO2005010494A3 (en) Multiplexed analyte detection
ATE519864T1 (de) Dna-konformation (loop-strukturen) bei normaler und anomaler genexpression
EP2002260A4 (en) Highly sensitive system and methods for analysis of troponin
ATE535612T1 (de) Toxizitätsscreeningverfahren
CY1113686T1 (el) Συσκευη bio-αισθητηρα και οι μεθοδοι χρησης της
WO2012024535A3 (en) Methods for determining the presence or risk of developing facioscapulohumeral dystrophy (fshd)
BRPI0707645B8 (pt) métodos in vitro para detecção de câncer em um indivíduo e para avaliação de prognóstico de um indivíduo tendo, ou suspeito de ter, câncer ovariano
ATE531820T1 (de) Gesundheitszustandstest
WO2009021131A3 (en) System and method for biological sample collection and analyte detection
ATE471512T1 (de) Verwendung des proteins s100a 12 als marker für kolorektalkarzinom
CY1110076T1 (el) Μεθοδος για τον καθορισμο της δεκτικοτητας σε αναστολεις chk1
WO2004057336A3 (en) Use of nicotinamide n-methyltransferase as a marker for colorectal cancer
EP2269065A4 (en) METHOD AND REAGENTS TO INCREASE THE SENSITIVITY OF METALOGRAPHIC ENZYME RECOGNITIONS
WO2009058331A3 (en) Biomarkers for the detection of early stage ovarian cancer
EP2520669A3 (en) Mild osteoathritis biomarkers and uses thereof
DE602005014386D1 (de) Verwendung von cyfra 21-1 und osteopontin als marker für kolorektalkarzinome
DK1664793T3 (da) Neurotoksisk aminosyre eller neurotoksisk derivat deraf forbundet med neurologiske lidelser
ATE529533T1 (de) Verfahren zum nachweis von analyten in einer probe
ATE333521T1 (de) Detektion von vancomycin-resistenten enterococcus-subspezies